Physicians' Academy for Cardiovascular Education

Agenda Topics ▼Video ▼Online-CME News ▼Meeting Reports Slides ▼About

ACC.19 ▼Diabetes & CVD ▼EAS 2019 ▼ESC 2019 ▼ESC Diabetes guidelines 2019 ▼ESC/EAS Guidelines dyslipidaemias 2019 ▼HFpEF: The essentials to know ▼LDL-c Expert Meeting ▼LDL-c Key Lessons ▼PCSK9 ▼

Management of AFrelated stroke

Slides (presentation) - Dec. 27, 2012

Share this page with your colleagues and friends:

Continue reading:

5 Things a cardiologist should know about diabetes

Slide Curriculum: Diabetes and cardiology

Slides (curriculum) - July 24, 2018

PACE Special: 5 Things a cardiologist should know about diabetes

Download - Download your free copy

Hypoglycemia in cardiovascular medicine: why worry?

10' education - Mar. 7, 2018 - Prof Guntram Schernthaner - Vienna, Austria - Online CME

ACS

Ischemic outcomes with antithrombotic regimes in AF patients with ACS or undergoing PCI

Literature - Oct. 14, 2019 - Potpara TS, et al. - Europace 2019

In-hospital initiation of PCSK9 inhibitor after ACS helps achieve LDL-c target at 8 weeks

Literature - Oct. 3, 2019 - Koskinas KC et al. - J Am Coll Cardiol. 2019

The 2019 ESC/EASD diabetes guidelines: a major paradigm shift in the management of T2DM

10' education - Sep. 30, 2019 - Paris, France - Prof. Francesco Cosentino, MD

Atherosclerosis

Primary and secondary efficacy endpoints met with siRNA against PCSK9

News - Aug. 27, 2019

CAC helps to identify people who will benefit from NOAC for primary prevention of ASCVD

Literature - Aug. 26, 2019 - Arps K et al. - Am J Cardiol 2019

High CAC score associated with increased mortality in young adults

Literature - Aug. 8, 2019 - Miedema MD et al. - JAMA Netw Open 2019

Atrial fibrillation

Ischemic outcomes with antithrombotic regimes in AF patients with ACS or undergoing PCI

Literature - Oct. 14, 2019 - Potpara TS, et al. - Europace 2019

Parental smoking increases AF risk in offspring

Literature - Oct. 10, 2019 - Groh CA et al., - J Am Coll Cardiol 2019

Long-term obesity and BMI change associated with increased risk for AF

Literature - Sep. 24, 2019 - Feng T et al., - Eur Heart J. 2019

CV Inflammation

Identification of determinants of iron deficiency in worsening HF

Literature - Oct. 10, 2019 - Van der Wal H et al., - Eur Heart J 2019

Residual inflammatory risk associated with IL-6 and IL-18 after IL-1β inhibition

Literature - Sep. 24, 2019 - Ridker PM et al. - Eur Heart J. 2019

CRP not only related to recurrent CV events, but also to cancer in patients with stable CVD

Literature - Sep. 11, 2019 - Van ’t Klooster CC et al. - Eur Heart J 2019

CVRM

Not only weight loss, but also maintaining a lower weight is important for a good CV risk profile

Literature - Oct. 14, 2019 - Berger SE et al., - J Am Heart Assoc. 2019

Parental smoking increases AF risk in offspring

Literature - Oct. 10, 2019 - Groh CA et al., - J Am Coll Cardiol 2019

Long-term obesity and BMI change associated with increased risk for AF

Literature - Sep. 24, 2019 - Feng T et al., - Eur Heart J. 2019

Diabetes

Heart Failure: What are the practical consequences of current and ongoing SGLT2i outcome trials?

10' education - Oct. 15, 2019 - Prof. Faiez Zannad, MD

Not only weight loss, but also maintaining a lower weight is important for a good CV risk profile

Literature - Oct. 14, 2019 - Berger SE et al., - J Am Heart Assoc. 2019

A transatlantic discussion on the new LDL-c guidelines: What are the key differences?

10' education - Oct. 11, 2019 - Prof. Christie Ballantyne, MD

Epigenetics in CVD

Primary endpoint not met for BET inhibitor in phase 3 trial

News - Sep. 30, 2019

The role of ALP as predictor of CV events and vascular calcification in CKD

10' education - June 15, 2019 - Dr. Mathias Haarhaus, MD

Epigenetic mechanisms targeting ALP: A pathway for prevention of vascular calcification?

10' education - Aug. 7, 2019 - Marta Ruiz-Ortega, PhD

ESC Diabetes guidelines 2019

Slides: 2019 ESC guidelines on diabetes, pre-diabetes and cardiovascular diseases - Expert insights and rationale

Slides (presentation) - Oct. 7, 2019 - Prof Francesco Cosentino, MD, Stockholm, Sweden - CME symposium held during ESC 2019

The 2019 ESC/EASD diabetes guidelines: a major paradigm shift in the management of T2DM

10' education - Sep. 30, 2019 - Paris, France - Prof. Francesco Cosentino, MD

New ESC/EASD Guidelines on diabetes no longer regard metformin as first-line therapy

News - Sep. 3, 2019

ESC/EAS Guidelines dyslipidaemias 2019

LDL-c targets in the ESC/EAS dyslipidaemia guidelines in a nutshell

10' education - Oct. 4, 2019 - Prof. Brian Ference, MD

Slides: LDL-c targets in the ESC/EAS dyslipidaemia guidelines in a nutshell

Slides (presentation) - Sep. 9, 2019 - ESC Paris, France - Prof. Brian A. Ference, M.D, University of Cambridge, United Kingdom - CME symposium held during ESC 2019

Rationale for the lower LDL-c targets in the 2019 ESC/EAS Dyslipidemia Guidelines

5' education - Sep. 9, 2019 - Paris, France - Prof. François Mach

Expert Meeting GLP-1, CVD & T2DM

Translation of novel approaches in CVD & diabetes to clinical practice

10' education - Mar. 22, 2018 - John Deanfield, Francesco Cosentino, Filip Knop - Online CME

Novel diabetes drugs in clinical management: Extending the opportunities

10' education - June 5, 2018 - Stefano Taddei, Cees Tack, Massimo Volpe - Online CME

Clinical trials in diabetes and CVD: What did we learn?

10' education - Mar. 22, 2018 - Filippo Crea, Angelyn Bethel, Eduard Montanya - Online CME

Familial Hypercholesterolemia

FH patients insufficiently treated, reveals global FH registry

News - Sep. 9, 2019

ANGPTL3 antibody halves LDL-c levels in HoFH patients in phase 3 trial

News - Aug. 15, 2019

Prevalence and relevance of elevated Lp(a) in familial hypercholesterolemia

5' education - May 24, 2019 - EAS-endorsed Lp(a) satellite meeting - Prof. Børge Nordestgaard, MD

GLP-1 RA & CVD

The diabetes challenge for cardiologists: The key things to understand

10' education - Sep. 2, 2019 - Prof. Naveed Sattar, MD

First oral GLP-1RA approved in the US

News - Oct. 2, 2019

The 2019 ESC/EASD diabetes guidelines: a major paradigm shift in the management of T2DM

10' education - Sep. 30, 2019 - Paris, France - Prof. Francesco Cosentino, MD

Heart Failure

NP metabolism associated with clinical outcomes in HF

5' education - Oct. 15, 2019 - Frank Gommans, MD, PhD

Heart Failure: What are the practical consequences of current and ongoing SGLT2i outcome trials?

10' education - Oct. 15, 2019 - Prof. Faiez Zannad, MD

Identification of determinants of iron deficiency in worsening HF

Literature - Oct. 10, 2019 - Van der Wal H et al., - Eur Heart J 2019

HFpEF: The essentials to know

HFpEF: Current and future clinical approaches to manage HFpEF

10' education - Aug. 27, 2018 - Burkert Pieske, MD - Berlin, Germany - Online CME

Slides: HFpEF: What are the most likely pathophysiological mechanisms involved in the disease

Slides (presentation) - Aug. 27, 2018 - Carolyn Lam, MD - Singapore

HFpEF: How to diagnose

10' education - Aug. 27, 2018 - Barry Borlaug - Rochester, MN, USA - Online CME

Hypertension

Decreased CV risk with an intervention targeting identified barriers to care

3' education - Aug. 31, 2019 - ESC 2019, Paris - Prof. J-D Schwalm

Oral K+-binding agent enables use of spironolactone in patients with resistant hypertension and CKD

Literature - Sep. 19, 2019 - Agarwal R et al., - The Lancet 2019

Community-wide salt restriction reduces blood pressure and incidence of hypertension

3' education - Sep. 2, 2019 - Paris, France - Prof. Jaime Miranda

Inflammation Expert Opinions

Ultime notizie sulla terapia: Un farmaco anti-infiammatorio riduce eventi cardiovascolari maggiori

5' education - Aug. 27, 2017 - ESC 2017, Barcelona, Spain

Breakthrough therapy: Anti-inflammatory drug can affect important CV outcomes

5' education - Aug. 27, 2017 - ESC 2017, Barcelona, Spain

Clinical implications of inhibiting inflammation as risk factor for progression of CVD

5' education - Aug. 27, 2017

Invest in your arteries

Estimating CV risk and treatment benefit

10' education - June 12, 2018 - Prof. Frank Visseren - Utrecht, The Netherlands - Online CME

Importance of hypertension in CVD prevention

10' education - June 12, 2018 - Prof. Richard Hobbs - Oxford, UK - Online CME

The role of lipids in CVD prevention: Lessons learned about statins

10' education - June 6, 2018 - Prof. Kees Hovingh - Amsterdam, The Netherlands - Online CME

Lipids

A transatlantic discussion on the new LDL-c guidelines: What are the key differences?

10' education - Oct. 11, 2019 - Prof. Christie Ballantyne, MD

In-hospital initiation of PCSK9 inhibitor after ACS helps achieve LDL-c target at 8 weeks

Literature - Oct. 3, 2019 - Koskinas KC et al. - J Am Coll Cardiol. 2019

Two phase 3 studies with siRNA against PCSK9 meet primary endpoints

News - Oct. 2, 2019

Lp(a)

Insights and lessons from the ODYSSEY Outcomes trial: Which patients benefit most?

10' education - Sep. 28, 2019 - Paris, France - Prof. Ph. Gabriel Steg

High Lp(a) levels associate with mortality, through low number of Kringle-IV type 2 repeats

Literature - Sep. 16, 2019 - Langsted A, et al. - Eur Heart J 2019

New ESC/EAS dyslipidemia guidelines advocate “lower is better” for LDL-c

News - Sep. 1, 2019

PCSK9

In-hospital initiation of PCSK9 inhibitor after ACS helps achieve LDL-c target at 8 weeks

Literature - Oct. 3, 2019 - Koskinas KC et al. - J Am Coll Cardiol. 2019

Two phase 3 studies with siRNA against PCSK9 meet primary endpoints

News - Oct. 2, 2019

The 2019 ESC/EASD diabetes guidelines: a major paradigm shift in the management of T2DM

10' education - Sep. 30, 2019 - Paris, France - Prof. Francesco Cosentino, MD

Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension: Key questions addressed

Online-CME - This course consists of 3 separate lectures

Why cardiologists should be more interested in PAH

3' education - Mar. 9, 2018 - VBWG at ACC, Orlando, FL, USA - Prof. Mardi Gomberg-Maitland, Falls Church, VA, USA - Online CME

Novel insights in the management and prognosis of pulmonary hypertension

5' education - Aug. 29, 2017 - ESC 2017, Barcelona, Spain - Prof Nazzareno Galiè - Bologna, Italy

Stroke

Optimism associated with reduced risk of CV events and all-cause mortality

Literature - Oct. 10, 2019 - Rozanski A, et al. - JAMA Network Open

Long-term treatment with dual antiplatelet therapy in patients with diabetes and stable CAD

3' education - Sep. 9, 2019 - Prof. Ph. Gabriel Steg

Systolic and diastolic hypertension independently associated with CV outcomes

Literature - July 22, 2019 - Flint AC et al. - N Engl J Med 2019

© 2006 - 2019 pace-cme.org - About